Browse the detailed record of transactions filed by 설상현, Chief Executive Officer. Officer active across 2 companies, notably 광동제약. In total, 10 filings have been recorded. The latest transaction was filed on 27 February 2026 — Purchase. Regulator: DART (FSS). All data is free.
Seol Sang-hyun is an Executive Director at Kwangdong Pharmaceutical, where he is responsible for managing operations and the company's strategy. His experience in the pharmaceutical sector allows him to effectively lead his team and ensure product quality.